Skip to main content
. 2021 Apr 13;17(6):363–374. doi: 10.1038/s41584-021-00603-4

Table 1.

Clinical features of gout in different sub-Saharan African countries

Region Southern Africa East Africa West Africa
Country South Africa South Africa Kenya Togo Nigeria Mali Cameroon
Study Cassim et al. (1994)9 Tikly et al. (1998)10 Oyoo et al.(2004)18 Mijiyawa et al.(2000)11 Adelowo et al. (2014)20 Kodio et al.(2015)17 Doualla-Bija et al.(2018)19
Demographics
Number of participants 107 90 21 160 146 100 174
Female-to-male ratio 1.0:6.6 1.0:3.3 1.0:9.5 1.0:159.0 1.0:2.8 1.2:1.0 1.0:1.1
Family history (%) NR 8.8 NR 10.6 NR NR NR
Mean (s.d.) age (years) Total 50.5 (11.5); 49.3 F; 57.0 M 54.3 (30–86) M; 55.3 (43–64) F 47.5 44.0 Total 53.4 (11.0); 52.8 (10.3) M; 54.9 (13.0) F 57.3 (10.0) 55.0 (14.3)a
Mean (s.d.) duration of symptoms (years) 3.4 (4.4) 5.4 (0.02–0.08) M; 2.7 (0.05–0.04) F NR 6.0 3.6 NR 7.5 (10.0)a
Pattern of joint involvement (%)
Monoarthritis 37.4 4.4 47.6 NR 50.0 36.0 NR
Oligoarthritis 28.0 51.2 19.1 NR 35.6 30.0 NR
Polyarthritis 34.6 44.4 33.3 NR 14.4 27.0 NR
Joints involved (%)
Knee 85.0 57.8 14.1 NR 55.5 92.0 NR
1st MTP joint 74.8 60.0 34.9 NR 14.4 22.0 NR
Ankles or feet 61.7 66.7 18.6 NR 34.4 45.0 NR
Wrists NR 45.6 NR NR 9.6 20.0 NR
Other features
Presence of tophi (%) 36.4 51.1 NR 21.9 6.2 4.0 35.1
Comorbidities (%)
Hypertension 40.2 60.6 61.5 26.3 49.3 76.0 35.6
Obesity NR 74.0 90.5 40.0 12.3 83.0 84.5
Diabetes NR 3.3 7.7 NR 4.1 13.0 13.2
Alcohol 79.0 75.3 100.0 83.1 17.8 5.0 67.2
Kidney disease 16.8 31.1 NR NR 0.7 37.0 NR
Diuretic therapy 44.9 36.8 NR 12.5 NR 64.0 NR

F, female; M, male; MTP, metatarsophalangeal; NR, not reported; s.d., standard deviation. aMedian (interquartile range).